JesperNors Profile Banner
Jesper Nors Profile
Jesper Nors

@JesperNors

Followers
158
Following
1K
Media
31
Statuses
177

MD, PhD | I study colorectal cancer recurrence

Regionshospitalet Randers
Joined November 2020
Don't wanna be here? Send us removal request.
@JesperNors
Jesper Nors
5 months
Jeg starter i hoveduddannelsen i kirurgi pr. 1. September med forløbet Randers-Aalborg-Randers. Drømmestilling! Jeg glæder mig enormt 🤩
0
0
4
@JesperNors
Jesper Nors
30 days
Vi søger 2 kollegaer til introduktionsstillinger i kirurgi på Kirurgisk Fællesafdeling, Regionshospitalet Randers. Ansøgningsfrist 31. Oktober!
0
0
0
@JesperNors
Jesper Nors
2 months
Hjertemagnyl reducerer risikoen for recidiv efter PI3K-muteret kolorektal cancer i ALASCCA-studiet | New England Journal of Medicine
Tweet card summary image
nejm.org
Aspirin reduces the incidence of colorectal adenoma and colorectal cancer among high-risk persons. Observational studies suggest that aspirin may also improve disease-free survival after diagnosis,...
0
0
0
@JesperNors
Jesper Nors
4 months
Rekordmange i absolutte tal… Der var formentlig også rekordmange “at risk”… #survivalanalysis
nyheder.tv2.dk
0
0
0
@JesperNors
Jesper Nors
5 months
Himmerlandscup 4. afdeling - det bliver varmt for Conrad 🥵 #bmx
0
0
1
@JesperNors
Jesper Nors
5 months
Var til hoveduddannelsessamtale i dag - krydser 🤞🏻 for et positivt opkald senere #kirurgi
1
0
2
@JesperNors
Jesper Nors
6 months
Kan bestemte bakterier måske være medvirkende til udvikling af early-onset colorectal cancer? 🦠 jeg prøver her at kvalificere resultaterne af et nyligt Nature studie til TV2.
Tweet card summary image
nyheder.tv2.dk
0
0
6
@JesperNors
Jesper Nors
7 months
Dutch study confirms findings of our Danish study (PMID: 37971197), reporting lower risk of recurrence in screen-detected vs non–screen-detected colorectal cancer patients - @AGA_CGH
cghjournal.org
Patients with screen-detected colorectal cancer (CRC) have a better stage-specific overall survival than non–screen-detected CRC. Currently, it is unknown if recurrence rates differ between screen-...
0
1
2
@JesperNors
Jesper Nors
8 months
🐴🩵
Tweet card summary image
sport.tv2.dk
0
0
0
@BMJOncology
BMJ Oncology
8 months
There is very little evidence presented in guidelines that current recommendations for cancer recurrence surveillance improve patient outcomes. https://t.co/C9co1u8SD9
0
6
18
@RandersRejsning
Randers-Rejsningen
9 months
Ny indløbssang på Sta-John 🐴@Randers_FC #sldk #mgp2025
1
1
10
@MolOncology
Molecular Oncology
9 months
🧬Whole-genome sequencing of cell-free DNA reveals DNA of tumor origin in plasma from patients with colorectal adenomas ➡️ https://t.co/F27ey4d6vE @amanda_fbj @adamjwidman @CtdnaDK @BalazsHalmosMD @JesperNors @j_ahrenfeldt @landau_lab @LindbjergC9416 #cfDNA #CRCSM
0
1
9
@JesperNors
Jesper Nors
9 months
Søg introduktionsstilling i kirurgi på Regionshospitalet Randers! 😷
0
0
1
@VickersBiostats
Andrew Vickers
10 months
There is no statistical solution to the problem of causal inference from observational data, it requires good scientific & statistical judgement, & knowledge of the literature. Folks like short cuts (propensity scores, E values etc) to avoid hard thinking. Short cuts don’t exist.
10
35
124
@JAMAOnc
JAMA Oncology
1 year
Individuals with a negative colonoscopy screening may not need a repeat exam for at least 20 years, according to a study of ~200,000 participants followed for up to 32 years. The re-screening interval may be tailored based on individuals’ risk profiles. https://t.co/ovsqy8WdEa
0
6
19
@RandersRejsning
Randers-Rejsningen
1 year
Rejsningen er kolossal! #sldk #rfcfcn #hesteliv
0
1
30
@JesperNors
Jesper Nors
1 year
🩵🐴 #randersfc
0
0
0